Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2016 12:00 ET | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Positive Results of Phase 1 Trial of Marizomib and Bevacizumab in Malignant Glioma

TORONTO and SAN DIEGO, June 04, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept,...
May 03, 2016 09:35 ET | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Expansion of Collaboration with Celgene in the Development of Marizomib for the Treatment of Gliomas

TORONTO and SAN DIEGO, May 03, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept,...
April 19, 2016 09:05 ET | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Positive Interim Results of Phase 1 Trial of Marizomib and Bevacizumab in Malignant Glioma

TORONTO and SAN DIEGO, April 19, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2...
April 18, 2016 09:05 ET | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Positive Preclinical Results for CBZed-Nano™ in Docetaxel-Resistant Prostate Cancer Models

TORONTO and SAN DIEGO, April 18, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2...